NCT00861458已完成1 期
A Phase 1, Open-Label, Randomized, 3-Way Crossover Study In Healthy Subjects To Estimate The Pharmacokinetics Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 14
- 试验地点
- 1
- 主要终点
- AUC inf, Cmax
研究概览
简要总结
This study will test two different formulations. The results will be used to select formulation for phase 3.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy volunteers.
排除标准
- •Standard for healthy volunteers.
研究组 & 干预措施
PF-00868554
Experimental
干预措施: Pharmacokinetics (Drug)
结局指标
主要结局
AUC inf, Cmax
时间窗: 2 days
次要结局
- Adverse events(2 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study in Healthy Volunteers to Investigate the Effect of Food on the Bioavailability of CytisineSmoking CessationNCT03268343Achieve Life Sciences24
Unknown
1 期
Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and SafetyHealthyNCT02586363Seoul St. Mary's Hospital30
已完成
1 期
A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New FormulationSmoking CessationNCT03509948Achieve Life Sciences13
已完成
1 期
Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.Healthy ParticipantsNCT04390776Pfizer164
已完成
1 期
Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult SubjectsInfection, Human Immunodeficiency VirusNCT01967771ViiV Healthcare16